DIA has awarded 15 scholarships to nationally recognized patient organizations that will cover registration fees and travel costs associated with attending the DIA 2011 Annual Meeting, June 19-21 in Chicago, IL.
With the launch of comparative effectiveness research (CER) and the Patient-Centered Research Outcomes Institute (PCORI), the importance of having advocates engaged in drug development is critical. The inaugural DIA Patient Advocacy Fellowship Program provides a chance for medical industry professionals to gather for a half-day of sessions designed to educate attendees on changes in federal health care policy and how policy may affect drug discovery and approval and patient access to new treatments. The program also provides information about how patient groups can get involved in this process to advocate on behalf of their members.
Fellowship recipients include:
- Alagille Syndrome Alliance
- Asthma and Allergy Foundation of America
- Autoimmune Diseases Association
- Hepatitis C Caring Ambassadors Program
- International Pemphigus & Pemphigoid Foundation
- Myasthenia Gravis Foundation
- National Alopecia Areata Foundation
- National Ataxia Foundation
- Pancreatic Cancer Action Network
- Parkinson's Disease Foundation
- Spinal Muscular Atrophy Foundation
- Susan G. Komen for the Cure
- Uniting Against Lung Cancer
For complete details regarding the DIA 2011 Annual Meeting visit www.diahome.org/registerdia2011.
DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices and related health care products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well being worldwide. Headquarters are in Horsham, Pa., USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India and Beijing, China.